• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Thrombus (2101); Vascular Dissection (3160)
Event Date 02/26/2019
Event Type  Injury  
Manufacturer Narrative
Date of publication journal article title: healing of femoral artery dissection after drug-coated balloon angioplasty: a case report with intravascular ultrasonography and angioscopy images sage open medical case reports volume 7: 1¿3 © the author(s) 2019 article reuse guidelines: sagepub.Com/journals-permissions doi: 10.1177/2050313x19834159 journals.Sagepub.Com/home/sco.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Patient presented with left leg intermittent claudication caused by atherosclerotic stenosis at left external iliac artery (eia) and middle of superficial femoral artery (sfa).Using intravascular ultrasonography (ivus) images, a 8.0¿40mm non-medtronic stent was deployed for eia lesion by contra-lateral approach.Dcb was chosen for treatment of 2cm lesion in the patient¿s (sfa).After preparation using 4.0¿ 40mm non-medtronic balloon, angioplasty using dcb (5.0¿40mm in.Pact admiral; medtronic, usa) was carried out at nominal pressure for 5min and resulted in 50% residual stenosis with linear dissection.Provisional stenting was not done because decent ante-grade blood flow allowed 10 extra minutes.Medication involved ongoing use of aspirin 100mg and rivaroxaban 15mg.Angiography 3 months from index procedure showed eia and sfa patency and healing of intimal dissection at sfa lesion was estimated by ivus.In angioscopy findings, red thrombus was seen in dissection cavity, but no white granular materials were seen at dcb dilated segment.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IN.PACT ADMIRAL PACLITAXEL-ELUTING PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8439867
MDR Text Key139442853
Report Number9612164-2019-00976
Device Sequence Number1
Product Code ONU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P140010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 03/15/2019
Initial Date FDA Received03/21/2019
Supplement Dates Manufacturer Received05/01/2019
Supplement Dates FDA Received05/02/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-